Skip to main content
FinSpry Logo
FinSpry
TCRX logo
TCRX
(NASDAQ)
TScan Therapeutics, Inc.
$1.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

TScan Therapeutics (TCRX) Stock Price & Financial Analysis

TScan Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.00 - $1.05
52-Week High$2.57
52-Week Low$0.88
Open$1.00
Volume672.90K
Average Volume (3M)672.90K
Market Cap131.16M
Shares Outstanding129.86M
Price to Sales (P/S)12.95
Price to Book (P/B)1.09
EV/EBITDA-0.57
Revenue (TTM)10.32M
Net Income (TTM)-129.77M
Free Cash Flow (TTM)-139.73M
EPS (TTM)$-1.00
Profit Margin-1256.81%
Operating Margin-1315.38%
Return on Equity (ROE)-105.40%
Debt to Equity0.76
50-Day MA$1.05
200-Day MA$1.44
52-Week Change-18.90%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About TScan Therapeutics

What is the current stock price for TCRX?

As of the latest trading session, TCRX stock trades at $1.01. The 52-week range is $0.88–$2.57, with a day range of $1.00–$1.05.

What is the P/E ratio for TCRX?

The P/E ratio (Price-to-Earnings) for TCRX is shown in the Key Statistics section. This valuation metric helps compare TScan Therapeutics, Inc. to industry peers.

Does TCRX pay dividends?

TScan Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TCRX?

Based on 1 analyst, the consensus for TCRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TCRX?

TScan Therapeutics's market capitalization is $131.2M, classifying it as a micro-cap company. TScan Therapeutics operates in the Healthcare sector within the Biotechnology industry.